Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Pasiniazid

Pasiniazid

pharmaceutical raw materials
Pasiniazid structure

Pasiniazid 

structure
  • CAS No:

    2066-89-9

  • Formula:

    C7H7NO3.C6H7N3O

  • Chemical Name:

    Pasiniazid

  • Synonyms:

    4-Pyridinecarboxylic acid,hydrazide,compd. with 4-amino-2-hydroxybenzoate (1:1);Isonicotinic acid hydrazide,mono(4-aminosalicylate);4-Pyridinecarboxylic acid,hydrazide,mono(4-amino-2-hydroxybenzoate);Salicylic acid,4-amino-,compd. with isonicotinic acid hydrazide;Salicylic acid,4-amino-,compd. with isoniazid;Salicylic acid,4-amino-,compd. with isonicotinic acid hydrazide (1:1);Benzoic acid,4-amino-2-hydroxy-,compd. with 4-pyridinecarboxylic acid hydrazide (1:1);p-Aminosalicylic acid isonicotinyl hydrazide;Dipasic;Fintozid;Isoniazid 4-aminosalicylate;Pasiniazide;Pasiniazid;Isonicotinic acid hydrazide p-aminosalicylate;Nidrapas;Paraniazide;Parasal INH;Pascidaber;Pashain;Pas-Hidracida;GEWO 399;6190-85-8

  • Categories:

    Active Pharmaceutical Ingredients  >  Synthetic Anti-infective Drugs

Description

Pasiniazid is an anti-TB and anti-leprosy drug, used to treat various types of TB and leprosy.

Pasiniazid Basic Attributes

290.27

290.10200

218-183-2

83J17CN0MN

758447

DTXSID50174700

2933399090

Characteristics

152

2.03010

COA

142-144 °C

380.8°C at 760 mmHg

184.1ºC

1.78E-06mmHg at 25°C

Safety Information

NONH for all modes of transport

3

22-36/37/38

26-36/37

Xn,Xi

P261-P305 + P351 + P338

H302-H315-H319-H335

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Fintosid

Pasiniazid Use and Manufacturing

antibacterial (tuberculostatic)

Computed Properties

Molecular Weight:290.27
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:2
Exact Mass:290.10150494
Monoisotopic Mass:290.10150494
Topological Polar Surface Area:152
Heavy Atom Count:21
Complexity:280
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

This product is a chemical synthesis of isoniazid (INH) and para-aminosalicylic acid (PAS). INH is mainly effective against mycobacteria in the growth and reproduction period, and may inhibit the synthesis of mycolic acid (myolic acid) of sensitive bacteria and cause cell wall rupture. PAS delays and blocks the acetylation process of INH in the body, enhances the bactericidal effect of the drug and delays the development of bacterial resistance. Clinically confirmed, in combination with other anti-tuberculosis drugs, the anti-tuberculosis efficacy of this product is significantly better than INH, and the incidence of adverse reactions is significantly lower than INH. Animal experiments show that the anti-tuberculosis efficacy of this product is about 5 times that of INH.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Chongqing Shengkai Pharmaceutical Co., Ltd.

    China China
    Active
  • Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.

    China China
    Active
  • Guizhou Shenqi Pharmaceutical Co., Ltd.

    China China
    Active

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.